Navigation Links
UCL academics awarded prestigious prizes for work on the heart
Date:9/11/2008

Two UCL academics have received prominent international awards from the European Society of Cardiology (ESC), in recognition of their work to understand and treat conditions of the heart.

Professor John Martin, Director of the UCL Centre for Cardiovascular Biology & Medicine and British Heart Foundation Professor of Cardiovascular Science, has been awarded the ESC's Gold Medal. The only other holder of this medal in the UK is Sir James Black, Nobel Laureate. Dr Paul Riley, UCL Institute of Child Health, has been awarded the Outstanding Achievement Award 2008 of the ESC Council on Basic Cardiovascular Science.

Commenting on the ESC awards, Professor Ed Byrne, Executive Dean of the UCL Faculty of Biomedical Sciences and Head of the Medical School, said: "Heart and circulatory disease is the UK's biggest killer and these awards demonstrate that UCL research is breaking new ground in the understanding and treatment of these conditions. I am delighted that the ESC has chosen to recognise the scientific endeavours of John and Paul and offer my sincere congratulations to them both."

Professor Martin has pursued an active research career, examining how the manufacture of platelets in the body causes blood to clot, how arteries age, and the protective role played by the gene for vascular endothelial growth factor (VEGF). His realisation that VEGF could be used therapeutically led him to start his own company, Ark Therapeutics, which is now taking gene therapy for vascular damage through clinical trials. He has also begun a phase III clinical trial to test whether the damage of heart attack can be repaired by direct injection of a patient's own bone marrow cells into the heart muscle.

Professor Martin also wrote the Heart Plan for Europe, a 'tool box' to help each country design its own bespoke prevention package for heart health, and he serves on a number of professional boards. As well as his scientific and medical endeavours, Professor Martin is a published writer and poet. He studied for his first degree in philosophy at a Spanish University and is fluent in Spanish and French, as well as being a keen artist.

The award made to Dr Paul Riley, Reader in the Molecular Medicine Unit at the UCL Institute of Child Health, recognises a landmark discovery in the field of basic cardiovascular science when his team found that a protein called Thymosin beta4 could mobilise dormant cells from the epicardium to form new blood vessels in the heart a major step towards finding a DIY mechanism to repair injury following heart attack.

Dr Riley said: "I'm very pleased indeed that my work has attracted professional recognition from the ESC." When not engaged in scientific pursuits, Dr Riley is a keen footballer, playing in an 8-a-side league with other scientists and clinicians close to the Institute in nearby Coram's Fields.


'/>"/>

Contact: Ruth Metcalfe
r.metcalfe@ucl.ac.uk
44-076-799-739
University College London
Source:Eurekalert

Related medicine news :

1. SpectraScience Awarded Patent for Correcting Image Misalignment
2. Phoenix Health Systems Awarded Level 2 Carnegie Mellon University eSCM-SP Certification
3. ACS Awarded $4 Million Contract to Provide Electronic Patient Records for City of New Orleans EMS
4. Malaria Vaccine Developer Sanaria Inc. and the University of Maryland Biotechnology Institute Awarded Collaborative, Multi-Year, US $600,000 NIH Phase I Small Business Innovation Research Grant
5. Canica Design Awarded Milestone U.S. Patent for Dynamic Wound Closure Systems
6. Availity Awarded Full EHNAC Accreditation
7. All-Med Services of Florida Awarded Medicare Competitive Bidding Contract
8. Nyer Medical Group, Inc. Announces Sale of Companys Florida Medical-Surgical Division; Pharmacy Division Awarded Two-Year Preferred Supplier Contract
9. TruFUSE(R) Patents Awarded
10. Pioneering stroke researcher awarded Canadas highest honor
11. Pathway Medical Technologies Awarded New Patent for Pathway PV(TM) Atherectomy System for Improved Differential Cutting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2017)... ... April 23, 2017 , ... Altura Communication Solutions, ... of Cisco Select certification and SMB specialization. Altura is now qualified to ... In earning the Select Certification, Altura fulfilled the training and exam requirements for ...
(Date:4/22/2017)... White Plains, NY (PRWEB) , ... April 22, ... ... Quarterly Report, which shows that U.S. consumers can save an average of 70% ... Even greater savings (up to 97%) are available when purchasing from other countries. ...
(Date:4/21/2017)... ... April 21, 2017 , ... An April 10 article ... ancient teeth, which reveal a great deal about prehistoric ice-age dental practitioners and their ... have been used to remove decayed dental matter, and that teeth were then filled ...
(Date:4/21/2017)... ... 21, 2017 , ... Contrary to popular perception, a new ... at noteworthy rates. Between 2002 and 2014, Salas-Wright and his colleagues found a ... the United States. The study, Trends in Fighting and Violence Among Adolescents ...
(Date:4/21/2017)... ... ... Brady (NYSE:BRC), a global leader in industrial and safety printing ... vinyl label materials received certification for the BS5609 British Marine Standard. This internationally recognized ... for use on chemical drums shipped by sea. , ÔÇťAchieving BS5609 certification ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/19/2017)... Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will ... at the Sheraton Hotel in Toronto, Ontario . ... Company is scheduled to present on Tuesday, May 2 at 10:00 ... of the Board, Tony Holler will also attend the ... For more details about ...
Breaking Medicine Technology: